REATA PHARMACEUTICALS INC Proceeds from Issuance Initial Public Offering
REATA PHARMACEUTICALS INC reported Proceeds from Issuance Initial Public Offering of $108.91 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-02.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceInitialPublicOffering · last filed 2019-02-28
- REATA PHARMACEUTICALS INC proceeds from issuance initial public offering for the quarter ending 2016-12-31 was $0.00.
- REATA PHARMACEUTICALS INC proceeds from issuance initial public offering for the quarter ending 2016-09-30 was $0.00.
- REATA PHARMACEUTICALS INC proceeds from issuance initial public offering for fiscal 2017 was $108.91M, a 68.32% increase from fiscal 2016.
- REATA PHARMACEUTICALS INC proceeds from issuance initial public offering for fiscal 2016 was $64.70M.
| Period end | Proceeds from Issuance Initial Public Offering 0 month | Proceeds from Issuance Initial Public Offering 3 month | Proceeds from Issuance Initial Public Offering 6 month | Proceeds from Issuance Initial Public Offering 9 month | Proceeds from Issuance Initial Public Offering 12 month |
|---|---|---|---|---|---|
| 2017-12-31 | $108.91M 10-K · filed 2018-03-02 | ||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-02 | $0.00 derived: sum of 2 quarters · filed 2018-03-02 | $64.70M 10-K · filed 2018-03-02 | ||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $64.70M 10-Q · filed 2016-11-14 | |||
| 2016-06-30 | $64.70M 10-Q · filed 2017-08-14 | ||||
| 2016-06-01 | $60.94M 10-K · filed 2019-02-28 | ||||
| 2016-05-25 | $60.90M 10-K · filed 2018-03-02 |